Minocycline 100mg (DrugBank: Minocycline)
14 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 0 |
6 | パーキンソン病 | 0 |
8 | ハンチントン病 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 1 |
46 | 悪性関節リウマチ | 0 |
84 | サルコイドーシス | 0 |
85 | 特発性間質性肺炎 | 0 |
90 | 網膜色素変性症 | 0 |
94 | 原発性硬化性胆管炎 | 0 |
162 | 類天疱瘡(後天性表皮水疱症を含む。) | 0 |
201 | アンジェルマン症候群 | 0 |
206 | 脆弱X症候群 | 0 |
280 | 巨大動静脈奇形(頚部顔面又は四肢病変) | 0 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04291456 (ClinicalTrials.gov) | January 31, 2020 | 18/11/2019 | Minocycline in MS: Confirmation of Benefit | Open-Label Trial of Minocycline in Early Multiple Sclerosis: Confirmation of Treatment Benefit | Multiple Sclerosis;Clinically Isolated Syndrome | Drug: Minocycline 100mg | University of Calgary | Hotchkiss Brain Institute, University of Calgary | Recruiting | 18 Years | 60 Years | All | 148 | Phase 3 | Canada |